POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company's busines… Read more
Market Cap & Net Worth: POMDOCTOR LIMITED American Depositary Shares (POM)
POMDOCTOR LIMITED American Depositary Shares (NASDAQ:POM) has a market capitalization of $3.79K ($3.79K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #46431 globally and #14468 in its home market, demonstrating a -5.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying POMDOCTOR LIMITED American Depositary Shares's stock price $0.41 by its total outstanding shares 9229 (9.23K).
POMDOCTOR LIMITED American Depositary Shares Market Cap History: 2025 to 2026
POMDOCTOR LIMITED American Depositary Shares's market capitalization history from 2025 to 2026. Data shows growth from $2.72K to $3.79K (0.00% CAGR).
POMDOCTOR LIMITED American Depositary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how POMDOCTOR LIMITED American Depositary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of POM by Market Capitalization
Companies near POMDOCTOR LIMITED American Depositary Shares in the global market cap rankings as of March 18, 2026.
Key companies related to POMDOCTOR LIMITED American Depositary Shares by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
POMDOCTOR LIMITED American Depositary Shares Historical Marketcap From 2025 to 2026
Between 2025 and today, POMDOCTOR LIMITED American Depositary Shares's market cap moved from $2.72K to $ 3.79K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.79K | +39.20% |
| 2025 | $2.72K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of POMDOCTOR LIMITED American Depositary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.79K USD |
| MoneyControl | $3.79K USD |
| MarketWatch | $3.79K USD |
| marketcap.company | $3.79K USD |
| Reuters | $3.79K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.